Evaluation of a strategy using pretherapeutic fiducial marker placement to avoid missing liver metastases

BACKGROUND: Hepatic surgery is appropriate for selected patients with colorectal liver metastases (CRLM). Advances in chemotherapy have led to modification of management, particularly when metastases disappear. Treatment should address all initial CRLM sites based on pretherapeutic cross‐sectional i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kepenekian, V., Muller, A., Valette, P. J., Rousset, P., Chauvenet, M., Phelip, G., Walter, T., Adham, M., Glehen, O., Passot, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551408/
https://www.ncbi.nlm.nih.gov/pubmed/31183451
http://dx.doi.org/10.1002/bjs5.50140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551408/
https://www.ncbi.nlm.nih.gov/pubmed/31183451
http://dx.doi.org/10.1002/bjs5.50140

Ejemplares similares